Nuclear addressing provides a clue for the transforming activity of amino-truncated CCN3 proteins

Journal of Cellular Biochemistry

Volumn 99, Issue 1, 2006, Pages 105-116

  Planque, Nathalie ^a   Li, Chang Long ^a   Saule, Simon ^b   Bleau, Anne Marie ^a   Perbal, Bernard ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT CURIE   (France)

Author keywords

CCN3 NOV CCN; Cell growth; Nuclear localization; Transcription; Tumorigenesis

Indexed keywords

CELL PROTEIN; CONNECTIVE TISSUE GROWTH FACTOR; CYSTEINE RICH PROTEIN 61; NUCLEAR PROTEIN; PROTEIN CCN; PROTEIN CCN3; PROTEIN NOV; PROTEIN SUBUNIT; REGULATOR PROTEIN; SECRETORY PROTEIN; SIGNAL PEPTIDE; SOMATOMEDIN BINDING PROTEIN; THROMBOSPONDIN 1; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; AVIAN LEUKOSIS ONCOVIRUS; CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CARCINOGENICITY; CELL DIFFERENTIATION; CELL GROWTH; CELL STRUCTURE; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CHICK EMBRYO; CONTROLLED STUDY; EMBRYO DEVELOPMENT; FIBROBLAST; FIBROSIS; NEGATIVE FEEDBACK; NEPHROBLASTOMA; NONHUMAN; NUCLEAR IMPORT; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; PROTEIN VARIANT; TRANSCRIPTION REGULATION; VIRUS DNA CELL DNA INTERACTION;

ANIMALS; BASE SEQUENCE; CELL LINE; CELL NUCLEUS; CRICETINAE; GREEN FLUORESCENT PROTEINS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR SEQUENCE DATA; NUCLEAR LOCALIZATION SIGNALS; RECOMBINANT PROTEINS; REPRESSOR PROTEINS; SEQUENCE DELETION; TRANSCRIPTION, GENETIC;

AVES;

EID: 33748077425     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20887     Document Type: Article

References (40)

1. Benini S, Perbal B, Zambelli D, Colombo MP, Manara MC, Serra M, Parenza M, Martinez V, Picci P, Scotlandi K. 2005. In Ewing's sarcoma CCNS(NOV) inhibits proliferation while promoting migration and invasion of the same cell type. Oncogene 24:4349-4361.
2. Bleau AM, Planque N, Perbal B. 2005. CCN proteins and cancer: Two to tango. Front Biosci 10:998-1009.
3. Brigstock DR. 2003. The CCN family: A new stimulus package. J Endocrinol 178:169-175.
4. Cervello M, Giannitrapani L, Labbozzetta M, Notarbartolo M, D'Alessandro N, Lampiasi N, Azzolina A, Montalto G. 2004. Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells. Ann NY Acad Sci 1028:432-439.
5. Chevalier G, Yeger H, Martinerie C, Laurent M, Alami J, Schofield P, Perbal B. 1998. NovH: Differential expression in developing kidney and Wilms' tumours. Am J Pathol 152:1563-1575.
6. Fu CT, Bechberger JF, Ozog MA, Perbal B, Naus CC. 2004. CCN3 (NOV) interacts with connexin43 in C6 glioma cells: Possible mechanism of connexin-mediated growth suppression. J Biol Chem 279:36943-36950.
7. Gellhaus A, Dong X, Propson S, Maass K, Klein-Hitpass L, Kibschull M, Traub O, Willecke K, Perbal B, Lye SJ, Winterhager E. 2004. Connexin43 interacts with NOV: A possible mechanism for negative regulation of cell growth in choriocarcinoma cells. J Biol Chem 279:36931-36942.
8. Gupta N, Wang H, McLeod TL, Naus CC, Kyurkchiev S, Advani S, Yu J, Perbal B, Weichselbaum RR. 2001. Inhibition of glioma cell growth and tumourigenic potential by CCN3 (NOV). Mol Pathol 54:293-299.
9. He J, Furmanski P. 1995. Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA. Nature 373:721-724.
10. Hurvitz JR, Suwairi WM, Van Hul W, El-Shanti H, Superti-Furga A, Roudier J, Holderbaum D, Pauli RM, Herd JK, Van Hul EV, Rezai-Delui H, Legius E, Le Merrer M, Al-Alami J, Bahabri SA, Warman ML. 1999. Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat Genet 23:94-98.
11. Ivkovic S, Yoon BS, Popoff SN, Safadi FF, Libuda DE, Stephenson RC, Daluiski A, Lyons KM. 2003. Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130:2779-2791.
12. Jiang WG, Watkins G, Fodstad O, Douglas-Jones A, Mokbel K, Mansel RE. 2004. Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. Endocr Relat Cancer 4:781-791.
13. Joliot V, Martinerie C, Dambrine G, Plassiart G, Brisac M, Crochet J, Perbal B. 1992. Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas. Mol Cell Biol 12:10-21.
14. Kiefer P, Dickson C. 1995. Nucleolar association of fibroblast growth factor 3 via specific sequence motifs has inhibitory effects on cell growth. Mol Cell Biol 15:4364-4374.
15. Kutz WE, Gong Y, Warman ML. 2005. WISP3, the gene responsible for the human skeletal disease progressive pseudorheumatoid dysplasia, is not essential for skeletal function in mice. Mol Cell Biol 25:414-421.
16. Kyurkchiev S, Yeger H, Bleau AM, Perbal B. 2004. Potential cellular conformations of the CCN3(NOV) protein. Cell Commun Signal 2:9.
17. Lau LF, Lam SC. 1999. The CCN family of angiogenic regulators: The integrin connection. Exp Cell Res 248:44-57.
18. Lee KW, Cohen P. 2002. Nuclear effects: Unexpected intracellular actions of insulin-like growth factor binding protein-3. J Endocrinol 175:33-40.
19. Lin SY, Makino K, Xia W, Matin A, Wen Y, Kwong KY, Bourguignon L, Hung MC. 2001. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 3:802-808.
20. Liu B, Lee HY, Weinzimer SA, Powell DR, Clifford JL, Kurie JM, Cohen P. 2000. Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis. J Biol Chem 275:33607-33613.
21. Mahony D, Kalionis B, Antalis TM. 1999. Plasminogen activator inhibitor type-2 (PAI-2) gene transcription requires a novel NF-kappaB-like transcriptional regulatory motif. Eur J Biochem 263:765-772.
22. Manara MC, Perbal B, Benini S, Strammiello R, Cerisano V, Perdichizzi S, Serra M, Astolfi A, Bertoni F, Alami J, Yeger H, Picci P, Scotlandi K. 2002. The expression of ccn3(nov) gene in musculoskeletal tumours. Am J Pathol 160:849-859.
23. McCallum L, Price S, Planque N, Perbal B, Prerce A, Whelton AD, Irvine AE. 2006. A novel mechanism for BCR-ABL action: stimulated secretion of CCN3 is involved in growth and differentiation regulation. Blood, in press.
24. Mo FE, Muntean AG, Chen CC, Stolz DB, Watkins SC, Lau LF. 2002. CYR61 (CCN1) is essential for placental development and vascular integrity. Mol Cell Biol 22:8709-8720.
25. Nakanishi Y, Kihara K, Mizuno K, Masamune Y, Yoshitake Y, Nishikawa K. 1992. Direct effect of basic fibroblast growth factor on gene transcription in a cell-free system. Proc Natl Acad Sci USA 89:5216-5220.
26. Olsnes S, Klingenberg O, Wiedlocha A. 2003. Transport of exogenous growth factors and cytokines to the cytosol and to the nucleus. Physiol Rev 83:163-182.
27. Perbal B. 1984. Transformation parameters expressed by tumor-virus transformed cells. In: Klein G. editor. Advances in viral oncology. Vol. 4. New York: Raven Press, pp 163-195.
28. Perbal B. 1999. Nuclear localization of NOV protein: A potential role for nov in the regulation of gene expression. Mol Pathol 52:84-91.
29. Perbal B. 2001. NOV (nephroblastoma overexpressed) and the CCN family of genes: Structural and functional issues. Mol Pathol 54:57-79.
30. Perbal B. 2004. CCN proteins: Multifunctional signalling regulators. Lancet 363:62-64.
31. Perbal B, Takigawa M. 2005. The CCN family of proteins: An overview. In: Perbal B, Takigawa M, editors. The CCN proteins: A new family of cell growth and differentiation regulators. London: Imperial College Press, pp 1-18.
32. Perbal B, Martinerie C, Sainson R, Werner M, He B, Roizman B. 1999. The C-terminal domain of the regulatory proteinNOVH is sufficient to promote interaction with fibulin 1C: A clue for a role of NOVH in cell-adhesion signaling. Proc Natl Acad Sci USA 96:869-874.
33. Planque N, Perbal B. 2003a. The CCN Proteins, a new family of cell growth regulators. In: Pandalai SG, editor. Recent research developments in human pathology. Vol. 1. 2003 Part II. Trivandrum: Transworld Research Network, p 333-369.
34. Planque N, Perbal B. 2003b. A structural approach to the role of CCN proteins in tumorigenesis. Cancer Cell Internat 3:1-15.
35. Planque N, Bleau AM, Perbal B. 2005. The CCN3 protein: A multifunctional cell growth regulator. In: Perbal B, Takigawa M, editors. The CCN proteins: A new family of cell growth and differentiation regulators. London: Imperial College Press, pp 239-257.
36. Reimers K, Antoine M, Zapatka M, Blecken V, Dickson C, Kiefer P. 2001. NoBP, a nuclear fibroblast growth factor 3 binding protein, is cell cycle regulated and promotes cell growth. Mol Cell Biol 21:4996-5007.
37. Su BY, Cai WQ, Zhang CG, Martinez V, Lombet A, Perbal B. 2001. The expression of ccn3 (nov) RNA and protein in the rat central nervous system is developmentally regulated. Mol Pathol 54:184-191.
38. Thomopoulos GN, Kyurkchiev S, Perbal B. 2001. Immunocytochemical localisation of NOVH protein and ultrastructural characteristics of NCI-H295R cells. J Submicrosc Cytol Pathol 33:251-260.
39. Wahab NA, Brinkman H, Mason RM. 2001. Uptake and intracellular transport of the connective tissue growth factor. A potential mode of action. Biochem J 359:89-97.
40. Xie D, Yin D, Wang HJ, Liu GT, Elashoff R, Black K, Koeffler HP. 2004. Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas. Clin Cancer Res 10:2072-2081.